Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms
- PMID: 7497862
- DOI: 10.2337/diacare.18.4.517
Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms
Abstract
Objective: To prospectively evaluate the frequency and severity of hypoglycemic episodes in IDDM subjects who declare themselves to have reduced awareness of hypoglycemia, to validate their self-designations in their natural environment, and to determine objectively the presence or absence of autonomic and neuroglycopenic symptoms associated with their low blood glucose (BG) levels.
Research design and methods: A total of 78 insulin-dependent diabetes mellitus (IDDM) subjects (mean age 38.3 +/- 9.2 years; duration of diabetes 19.3 +/- 10.4 years) completed two sets of assessments separated by 6 months. The assessments included reports of frequency and severity of low BG, symptoms associated with low BG, and a BG symptom/estimation trial using a hand-held computer (HHC). Diaries of hypoglycemic episodes were kept for the intervening 6 months. HbA1 levels were determined at each assessment.
Results: Of the subjects, 39 declared themselves as having reduced awareness of hypoglycemia (reduced-awareness subjects). There were no differences between these reduced-awareness subjects and aware subjects with regard to age, sex, disease duration, insulin dose, or HbA1. During the HHC trials, reduced-awareness subjects were significantly less accurate in detecting BG < 3.9 mmol/l (33.2 +/- 47 vs. 47.6 +/- 50% detection, P = 0.001) and had significantly fewer autonomic (0.41 +/- 0.82 vs. 1.08 +/- 1.22, P = 0.006, reduced-awareness vs. aware) and neuroglycopenic (0.44 +/- 0.85 vs. 1.18 +/- 1.32, P = 0.004, reduced-awareness vs. aware) symptoms per subject. Prospective diary records revealed that reduced-awareness subjects experienced more moderate (351 vs. 238, P = 0.026) and severe (50 vs. 17, P = 0.0062) hypoglycemic events. The second assessment results were similar to the first and verified the reliability of the data.
Conclusions: IDDM subjects who believe they have reduced awareness of hypoglycemia are generally correct. They have a history of more moderate and severe hypoglycemia, are less accurate at detecting BG < 3.9 mmol/l, and prospectively experience more moderate and severe hypoglycemia than do aware subjects. Neither disease duration nor level of glucose control explains their reduced awareness of hypoglycemia. Reduced-awareness individuals may benefit from interventions designed to teach them to recognize all of their potential early warning symptoms.
Similar articles
-
Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial.Diabetes Care. 2013 Dec;36(12):4063-70. doi: 10.2337/dc13-1004. Epub 2013 Oct 15. Diabetes Care. 2013. PMID: 24130355 Free PMC article. Clinical Trial.
-
Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.Diabetes Care. 1998 Jun;21(6):977-82. doi: 10.2337/diacare.21.6.977. Diabetes Care. 1998. PMID: 9614617 Clinical Trial.
-
A multicenter evaluation of blood glucose awareness training-II.Diabetes Care. 1995 Apr;18(4):523-8. doi: 10.2337/diacare.18.4.523. Diabetes Care. 1995. PMID: 7497863 Clinical Trial.
-
Recurrent nocturnal hypoglycemic hemiplegia: a case report and review of the literature.Endocr J. 2024 Apr 30;71(4):409-416. doi: 10.1507/endocrj.EJ23-0324. Epub 2024 Mar 9. Endocr J. 2024. PMID: 38346770 Review.
-
Type 1 diabetes mellitus and school: a review.Pediatr Diabetes. 2011 Feb;12(1):63-70. doi: 10.1111/j.1399-5448.2010.00654.x. Pediatr Diabetes. 2011. PMID: 20546162 Review. No abstract available.
Cited by
-
Quality of life, diabetes-related stress and treatment satisfaction are correlated with glycemia risk index (GRI), time in range and hypoglycemia/hyperglycemia components in type 1 diabetes.Endocrine. 2024 May 24. doi: 10.1007/s12020-024-03846-9. Online ahead of print. Endocrine. 2024. PMID: 38787511
-
Neurological dysfunction screening in a cohort of adolescents with type 1 diabetes: a six-year follow-up.Front Med (Lausanne). 2024 May 9;11:1331145. doi: 10.3389/fmed.2024.1331145. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38784238 Free PMC article.
-
Preparedness of diabetic patients for receiving telemedical health care: A cross-sectional study.J Family Med Prim Care. 2024 Mar;13(3):1004-1011. doi: 10.4103/jfmpc.jfmpc_1024_23. Epub 2024 Apr 4. J Family Med Prim Care. 2024. PMID: 38736819 Free PMC article.
-
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals.Diabetologia. 2024 Jun;67(6):1095-1106. doi: 10.1007/s00125-024-06116-5. Epub 2024 Mar 1. Diabetologia. 2024. PMID: 38427076 Free PMC article.
-
Use of machine learning to identify characteristics associated with severe hypoglycemia in older adults with type 1 diabetes: a post-hoc analysis of a case-control study.BMJ Open Diabetes Res Care. 2024 Feb 27;12(1):e003748. doi: 10.1136/bmjdrc-2023-003748. BMJ Open Diabetes Res Care. 2024. PMID: 38413176 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous